Company profile
PharmNovo company profile
PharmNovo's goal is to develop novel Delta Opioid Receptor Agonists that are safe and effective for chronic pain treatment (DORAs). This is a very different target than traditional opioid drugs, which have caused an epidemic of addiction and toxicity. The company addresses the significant unmet medical need for safe and effective chronic pain treatments, which affects up to 30% of the adult population in the United States and Europe.
Business identity
- Website
- https://www.pharmnovo.com/
- Contact email
- [email protected]
- Phone number
- +46 (0)705 44 32 50
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2008-01-01, Year
Headquarters
- Headquarters
- Byumba, Northern Province, Rwanda
- Postal code
- SE223 81
- Country code
- RW
- Continent
- Africa